These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32878695)

  • 1. Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer.
    Nylén C; Eriksson FB; Yang A; Aniss A; Turchini J; Learoyd D; Robinson BG; Gill AJ; Clifton-Bligh RJ; Sywak MS; Glover AR; Sidhu SB
    Am J Surg; 2021 May; 221(5):886-892. PubMed ID: 32878695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection.
    Laird AM; Gauger PG; Miller BS; Doherty GM
    World J Surg; 2012 Jun; 36(6):1268-73. PubMed ID: 22270997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma.
    Kim Y; Roh JL; Song D; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2020 Oct; 122(5):906-913. PubMed ID: 32588461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Retrospective Cohort Study of Two Clinical Centers.
    Yang Z; Heng Y; Lin J; Lu C; Yu D; Tao L; Cai W
    Cancer Res Treat; 2020 Oct; 52(4):1010-1018. PubMed ID: 32599980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Patient and Tumor Characteristics on Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Guide for Selective Node Dissection.
    Altiner S; Kozan R; Emral AC; Taneri F; Karamercan A
    Arch Iran Med; 2022 Nov; 25(11):730-736. PubMed ID: 37543897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma.
    Lang BH; Tang AH; Wong KP; Shek TW; Wan KY; Lo CY
    Ann Surg Oncol; 2012 Oct; 19(11):3472-8. PubMed ID: 22565664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma（cT1N0）.
    Zhou B; Qin J
    Eur J Surg Oncol; 2021 Apr; 47(4):882-887. PubMed ID: 33092967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
    Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
    Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level VI lymph node dissection does not decrease radioiodine uptake in patients undergoing radioiodine ablation for differentiated thyroid cancer.
    Yoo D; Ajmal S; Gowda S; Machan J; Monchik J; Mazzaglia P
    World J Surg; 2012 Jun; 36(6):1255-61. PubMed ID: 22430670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Dose RAI Therapy Justified by Pathological N1a Disease Revealed by Prophylactic Central Neck Dissection for cN0 Papillary Thyroid Cancer Patients: Is it Superior to Low-Dose RAI Therapy?
    Wei L; Bai L; Zhao L; Yu T; Ma Q; Ji B
    World J Surg; 2019 May; 43(5):1256-1263. PubMed ID: 30684002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reoperative central lymph node dissection for incidental papillary thyroid cancer can be performed safely: A retrospective review.
    Hall CM; LaSeur DC; Snyder SK; Lairmore TC
    Int J Surg; 2018 Aug; 56():102-107. PubMed ID: 29920338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
    Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
    Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic central lymph node dissection in cN0 papillary thyroid cancer: a comparative study of via breast and transoral approach versus via breast approach alone.
    Qiu R; Fu J
    Front Endocrinol (Lausanne); 2024; 15():1356739. PubMed ID: 38774230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic central lymph node dissection in cN0 patients with papillary thyroid carcinoma: A retrospective study in China.
    Xue S; Wang P; Liu J; Li R; Zhang L; Chen G
    Asian J Surg; 2016 Jul; 39(3):131-6. PubMed ID: 26117203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma.
    Feng JW; Qu Z; Ye J; Hong LZ; Liu SY; Wang F; Jiang Y; Hu J
    Surgery; 2021 Dec; 170(6):1670-1679. PubMed ID: 34275617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
    Ryu YJ; Cho JS; Park MH; Yoon JH
    BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central node dissection in papillary thyroid carcinoma in the era of near-infrared fluorescence.
    Kuczma P; Demarchi MS; Leboulleux S; Trésallet C; Mavromati M; Djafarrian R; Mabilia A; Triponez F
    Front Endocrinol (Lausanne); 2023; 14():1110489. PubMed ID: 37124759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.
    Popadich A; Levin O; Lee JC; Smooke-Praw S; Ro K; Fazel M; Arora A; Tolley NS; Palazzo F; Learoyd DL; Sidhu S; Delbridge L; Sywak M; Yeh MW
    Surgery; 2011 Dec; 150(6):1048-57. PubMed ID: 22136820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
    Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
    Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Postoperative Adjuvant Radioactive Iodine Ablation Therapy Always Necessary for Intermediate-Risk Papillary Thyroid Cancer Patients With Central Neck Metastasis?
    Han K; Noh HM; Jeong HM; Lim YC
    Ann Surg Oncol; 2021 Nov; 28(12):7533-7544. PubMed ID: 34043093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.